NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Dan:

I believe you mis-apprehend the issue in this threaded discussion. Let me make it simple:

1. Material negative events must be disclosed within a reasonable time frame. The issue is whether the particular described occurrence is subject to the SEC 4 business day window in terms of disclosure. If so, when does the clock start.

2. Notwithstanding item 1 hereinabove, which I think irrelevant for my own evaluative purposes, it is my opinion that investors are unwise to conclude that company silence, at this stage, connotes either trial success or failure. Absence of company disclosure at this stage is neutral and there are other and more telling indicia pointing to trial success.

Like you, I believe that the trial will turn out to be successful. For me it is not really a question of whether the trial will be successful but rather to what extent.

Peace my friend, we are on the same team.